Skip to content Skip to main menu
Cordance Medical
Menu
  • The Problem
    • The Blood-Brain Barrier
    • Brain Cancers
    • Alzheimer’s Diseases
    • Parkinson’s Disease
  • Our Solution
    • Our Solution
    • Our Applications
    • Our Product Map
  • Our Culture
    • Our Team
  • News & Publications
    • News
    • Publications
  • Contact
illustration of medical structure background

From Our Newsroom

News

Cordance Medical and EXACT Therapeutics Announce Early Encouraging Data in Brain Cancer Mice Model

January 28, 2025

Abyssinia Biosciences and Cordance Medical announce a partnership to explore the diagnostic and therapeutic utility of focused ultrasound technology in combination with soluble oligomer targeting mAbs

January 23, 2025

Cordance Medical Founder to Speak on Therapeutic Ultrasound Innovations at PMWC 2025

January 17, 2025

Presenting at R42 x Perkins Coie – AI & Longevity Showcase

January 7, 2025

Cordance Medical Secures European Union Patent for Groundbreaking Blood-Brain Barrier Technology

December 19, 2024

Poster Presentation at ISTU 2024

November 11, 2024

Cordance Medical Receives NIH/NCI SBIR Phase I Grant to Advance Non-Invasive Focused Ultrasound for Brain Tumor Liquid Biopsy in Glioma Models

September 19, 2024

Microvascular Therapeutics and Cordance Medical Announce Strategic Partnership

September 16, 2024

Cordance Medical Announces Triple Patent Grant to Revolutionize Treatment of Brain Diseases with its Innovative NeuroAccess Platform

April 17, 2024

Cordance Medical Announces Agreement with Stanford Medicine’s Airan and Williams Labs for Precision Neuropsychiatry with Ultrasonic Drug Uncaging Technology

December 6, 2023

Posts navigation

← Older posts
Cordance Medical logo in white

2483 Old Middlefield Way
Suite 120
Mountain View, CA 94043
info@cordancemedical.com

Our Company

  • Our Team
  • Newsroom

Our Vision

  • The Problem
  • Our Solution
© 2025 All Rights Reserved. Site by Colleen LeMasters Creative.